16
Participants
Start Date
February 19, 2019
Primary Completion Date
April 3, 2019
Study Completion Date
April 3, 2019
AST2818 Tablets
AST2818 Tablets: Period 1 Fasted from 10 hours prior to dosing with 80 mg AST2818 tablet (p o, once) and 4 hours after dosing on day 1. Period 2 Allocated high-fat meal prior to dosing with 80 mg AST2818 tablet (p o, once) and fasted 4 hours after dosing on day 1.
AST2818 Tablets
AST2818 Tablets: Period 1 allocated high-fat meal prior to dosing with 80 mg AST2818 tablet (p o, once) and fasted 4 hours after dosing on day 1. Period 2 fasted from 10 hours prior to dosing with 80 mg AST2818 tablet (p o, once)and 4 hours after dosing on day 1.
Hunan Provincial Tumor Hospital, Changsha
Lead Sponsor
Allist Pharmaceuticals, Inc.
INDUSTRY